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SP1 SP2 SP3 SP4
You mean you can use scale down semi-
continuous system to assess the performance of 
a perfusion process?
Yes, I compared my results with a push-to-lowa
approach using a lab-scale perfusion bioreactor!
He is right, from the semi-
continuous experiment it is 
possible to
2. Predict CSPRmin


































































































































































Perfusion Semi-continuous (ST) Fed-Batch





































Perfusion Semi-continuous (ST) Semi-continuous (DWP)
Stable operation was achieved using 
the capacitance signal
4. Impact on growth and productivity
Determination of CSPRmin across scales
Figure 1: Viable cell density of the  4 clones in (A) fed-batch bioreactorsb (B) semi-continuous shake tubes (C) perfusion bioreactors and (D) on-line 
capacitance signal used to increment the biomass set-point (SP) progressively  (SP 1 to 4)
Figure 2: CSPRmin calculated at SP4 for perfusion and at the VCDmax 
for ST (n=2) and DWP (n=6)
Figure 3: Bioreactor volumetric productivity in perfusion, semi-
continuous and fed-batch (increased by respectively 4.1, 3.6, 5.6 and




Figure 4: Growth and productivity in perfusion (A) Biomass (B) Bleed fraction




The good, the bad and the ugly… 
clone in perfusion
